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TRIzol treatment of secretory phase endometrium
allows combined proteomic and mRNA
microarray analysis of the same sample in
women with and without endometriosis
Amelie Fassbender, Peter Simsa, Cleophas M Kyama, Etienne Waelkens, Attila Mihalyi, Christel Meuleman,
Olivier Gevaert, Raf Van de Plas, Bart de Moor and Thomas M D’Hooghe
1,2,3,4*
Since publication of our article [1], we have realised that
we did not include the full data in Table 1 and missed
the word (TOF) in the result/discussion section. We
have provided here the adapted sentence and another
version of the table, including all the information
intended.
Results/Discussion
“Therefore, we plan to repeat this study in a larger sam-
ple size including well defined endometrial samples
obtained during menstrual, follicular and secretory
phase, to validate the reproducibility of SELDI-TOF MS
technology in these samples and to identify the protein
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Table 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2]
Protein Mass in Da
Osteoglycin (OGN/4969) 33,922
Interleukin-6 signal transducer (IL6ST/3572) isoform 1 103,537
isoform 2 37,499
Cytochrome P450, Family 2, Subfamily J, polypeptide 2 (CYP2J2/1573) 57,611
Carboxypeptidase E (CPE/1363) 53,151
Fibronectin 1 (FN1/2335) different isoforms
1. 262,607
2. 71,943
3. 259,198
4. 222,944
5. 243,316
6. 240,477
7. 268,894
8. 252,793
9. 246,670
10. 239,608
11. 262,388
12. 221,274
13. 249,304
14. 249,384
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expensive and labour intense requiring High-performance
liquid chromatography or high-pressure liquid chromato-
graphy (HPLC) and matrix assisted laser desorption ioni-
zation Time-of-Flight-Mass Spectrometry (MALDI-TOF/
TOF MS).”
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Table 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2]
(Continued)
15. 272,302
Synuclein, gamma (SNCG/6623) 13,331
BAI1-associated protein 2 (BAIAP2/10458) different isoforms
1. 60,868
2. 59,014
3. 56,626
4. 57,359
5. 57,445
6. 57,430
Protocadherin 17 (PCDH17/27253) different isoforms
1. 126,229
2. 96,570
Protein tyrosine phosphatase, receptor type, R (PTPRR/5801) Alpha 73,834 Da
Gamma 46,581Da
Delta 51,046Da
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